ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.610
+0.190 (13.38%)
At close: Aug 21, 2026, 4:00 PM EDT
1.590
-0.020 (-1.24%)
After-hours: Aug 21, 2026, 7:41 PM EDT
ProKidney Employees
ProKidney had 231 employees as of December 31, 2025. The number of employees increased by 27 or 13.24% compared to the previous year.
Employees
231
Change (1Y)
27
Growth (1Y)
13.24%
Revenue / Employee
$3,541
Profits / Employee
-$364,325
Market Cap
486.74M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 231 | 27 | 13.24% |
| Dec 31, 2024 | 204 | 41 | 25.15% |
| Dec 31, 2023 | 163 | 76 | 87.36% |
| Dec 31, 2022 | 87 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Foghorn Therapeutics | 106 |
| Editas Medicine | 87 |
| Larimar Therapeutics | 71 |
| Lexeo Therapeutics | 63 |
| Atea Pharmaceuticals | 55 |
| Eupraxia Pharmaceuticals | 49 |
| X4 Pharmaceuticals | 45 |
| Compass Therapeutics | 39 |
PROK News
- 12 days ago - ProKidney reports Q2 EPS (15c), consensus (14c) - TheFly
- 12 days ago - ProKidney Quarterly report: Q2 2026 - Filings
- 12 days ago - ProKidney Earnings release: Q2 2026 - Filings
- 2 months ago - ProKidney Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - ProKidney appoints Kenneth Locke as chief technical officer - TheFly
- 2 months ago - ProKidney Appoints Kenneth Locke as Chief Technical Officer - GlobeNewsWire
- 3 months ago - ProKidney Transcript: AGM 2026 - Transcripts
- 3 months ago - ProKidney reports Q1 EPS (14c), consensus (14c) - TheFly